We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$558M
AUM Growth
+$80.9M
(+17%)
Cap. Flow
+$74.9M
Cap. Flow
% of AUM
13.41%
Top 10 Holdings %
Top 10 Hldgs %
4.09%
Holding
1,998
New
778
Increased
301
Reduced
272
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$3.2M |
| 2 |
Boeing
BA
|
+$2.64M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.42M |
| 4 |
Amgen
AMGN
|
+$2.03M |
| 5 |
Elevance Health
ELV
|
+$1.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.64M |
| 2 |
Lockheed Martin
LMT
|
+$2.31M |
| 3 |
Cigna
CI
|
+$2.21M |
| 4 |
Wells Fargo
WFC
|
+$2.18M |
| 5 |
Paychex
PAYX
|
+$1.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Healthcare | 15.64% |
| 3 | Consumer Discretionary | 14.34% |
| 4 | Industrials | 14.21% |
| 5 | Financials | 12.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Lloyds Banking Group
LYG
$89B
| $234K | 0.04% |
+106,476
| New | +$244K |
|
|
RPTX
902
DELISTED
Repare Therapeutics
RPTX
| $233K | 0.04% |
22,021
-26,793
| -55% | -$276K |
|
903
Enova International
ENVA
$6.27B
| $233K | 0.04% |
4,384
-1,370
| -24% | -$64.6K |
|
904
Trex
TREX
$4.57B
| $233K | 0.04% |
+3,551
| New | +$198K |
|
905
Bankunited
BKU
$3.36B
| $232K | 0.04% |
+10,787
| New | +$222K |
|
906
Forward Air
FWRD
$466M
| $232K | 0.04% |
+2,190
| New | +$224K |
|
907
IES Holdings
IESC
$12B
| $232K | 0.04% |
+4,080
| New | +$195K |
|
908
Independent Bank Corp
IBCP
$774M
| $232K | 0.04% |
+13,679
| New | +$234K |
|
|
KZR
909
DELISTED
Kezar Life Sciences
KZR
| $232K | 0.04% |
+9,464
| New | +$246K |
|
910
Warrior Met Coal
HCC
$4.26B
| $232K | 0.04% |
5,944
-322
| -5% | -$11.7K |
|
911
Telos
TLS
$346M
| $231K | 0.04% |
+90,409
| New | +$214K |
|
912
FirstEnergy
FE
$28.5B
| $231K | 0.04% |
5,951
+786
| +15% | +$30.8K |
|
913
Stock Yards Bancorp
SYBT
$2.43B
| $231K | 0.04% |
+5,081
| New | +$238K |
|
914
Digi International
DGII
$2.55B
| $230K | 0.04% |
+5,847
| New | +$201K |
|
915
POSCO
PKX
$16.1B
| $230K | 0.04% |
+3,113
| New | +$226K |
|
916
Comcast
CMCSA
$80.9B
| $230K | 0.04% |
+5,540
| New | +$220K |
|
917
Asana
ASAN
$1.79B
| $230K | 0.04% |
10,441
-14,463
| -58% | -$290K |
|
918
Oil States International
OIS
$512M
| $229K | 0.04% |
30,721
+17,705
| +136% | +$129K |
|
919
Kanzhun
BZ
$7.03B
| $229K | 0.04% |
+15,230
| New | +$255K |
|
920
Braze
BRZE
$2.65B
| $228K | 0.04% |
+5,217
| New | +$177K |
|
921
Eastman Chemical
EMN
$7.74B
| $228K | 0.04% |
2,724
-736
| -21% | -$59.8K |
|
922
Aquestive Therapeutics
AQST
$468M
| $228K | 0.04% |
+138,145
| New | +$250K |
|
923
Allogene Therapeutics
ALLO
$604M
| $228K | 0.04% |
45,831
+259
| +0.6% | +$1.4K |
|
924
Myriad Genetics
MYGN
$515M
| $228K | 0.04% |
+9,825
| New | +$214K |
|
925
Western Union
WU
$2.55B
| $228K | 0.04% |
19,410
-41,376
| -68% | -$477K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q2 2023 Portfolio in Review
As of Q2 2023, XTX Topco held 1,998 positions worth $558M, up 17% from $477M the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.
XTX Topco deployed $74.9M of net new capital in Q2 2023, opening 778 new positions and adding to 301 existing holdings. Its largest new stake was Target: 21,561 shares worth $2.84M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Lockheed Martin, an estimated $2.31M trimmed.
- XTX Topco's largest Q2 2023 buy was Target: 21,561 shares worth $2.84M.
- XTX Topco added most to Alphabet (Google) Class A in Q2 2023, an estimated $2.42M increase.
- XTX Topco's biggest Q2 2023 reduction was Lockheed Martin, cutting an estimated $2.31M.
- XTX Topco fully exited Regeneron Pharmaceuticals in Q2 2023, selling an estimated $2.64M.
- XTX Topco's ten largest holdings make up 4.1% of its $558M portfolio in Q2 2023.
- XTX Topco opened 778 new positions and closed 643 in Q2 2023.
- XTX Topco's portfolio value rose 17% quarter-over-quarter to $558M.
Based on XTX Topco's 13F filing for Q2 2023, filed 14 Aug 2023.